Drug Chatter -- Tracking biopharma stock chatter

Profile for Exelixis, Inc. (EXEL)

« Back to company index

EXEL Chatter Timeline

Stock Ticker for EXEL

Most Active Tweeters for EXEL

UserTweets
@TickerReport 16
@SleekMoneycom 16
@intercooleronli 15
@CFinancialNews 14
@chaffeybreeze 12

Recent Tweets for EXEL

TheMarketsDaily @TheMarketsDaily
Brokerages Set Exelixis, Inc. $EXEL Price Target at $26.51 https://t.co/RyUAPds1uO
September 25th 2017, 5:09pm
AlpacaAlerts @AlpacaAlerts
$EXEL red today w/ 11 ? signals like three inside down. Sup/Res=23.06/23.65. Wanna short? https://t.co/Kb9PahiuSe https://t.co/0k04qjIj9p
September 25th 2017, 4:09pm
1MinuteStock @1MinuteStock
We calculated 21-day Expected Return of $EXEL for you: -7.24% https://t.co/46E2WrBpDC
September 25th 2017, 4:09pm
CFinancialNews @CFinancialNews
Oppenheimer Holdings, Inc. Reiterates “Hold” Rating for Exelixis, Inc. $EXEL https://t.co/GlEmHw1lJY
September 25th 2017, 4:09pm
intercooleronli @intercooleronli
Oppenheimer Holdings, Inc. Reiterates “Hold” Rating for Exelixis, Inc. $EXEL https://t.co/udWFdbKCK2
September 25th 2017, 4:09pm
MaisaCorp @MaisaCorp
$EXEL Daiichi Sankyo said that it intends to submit a Japanese regulatory application for esaxerenone for an essential hypertension
September 25th 2017, 4:09pm
MaisaCorp @MaisaCorp
$EXEL Daiichi Sankyo's Trial for Hypertension Treatment Esaxerenone Meets Primary Endpoint
September 25th 2017, 4:09pm
SwingTradeBot @SwingTradeBot
Recent $EXEL technical alerts: Fell Below 50 DMA plus 8 more alerts... https://t.co/R8mMMMOolt
September 25th 2017, 3:09pm
kjilly @kjilly
Boost for $EXEL as partner Daiichi Sankyo cues up #hypertension drug filing #FDA #highbloodpressure #biotech #pharma https://t.co/dCMErXnEIB
September 25th 2017, 1:09pm
stockboardinc @stockboardinc
$EXEL Exelixis Provides Update on Collaborator Daiichi Sankyo’s Phase 3 Clinical Progress with Esaxereno... - https://t.co/VBRJs6BaDG
September 25th 2017, 12:09pm
dakotafinancial @dakotafinancial
OxFORD Asset Management LLP Acquires New Stake in Exelixis, Inc. $EXEL https://t.co/673jweFf2G
September 25th 2017, 11:09am
leahanneta @leahanneta
10:45 ET Volume Leader #69 - EXEL 1,546,349 Exelixis Inc $EXEL 24.04 -0.43 -1.76% High today of 25.10 day low https://t.co/siPNeiiEQj
September 25th 2017, 11:09am
StockGodd @StockGodd
@timeout2575 $EXEL what were you saying... lol https://t.co/U9HEeErPKK
September 25th 2017, 10:09am
brockthornhill @brockthornhill
RT @mikegoodma: Esaxerenone achieves P3 primary endpt in hypertension. $EXEL in line for ~$150m in MS from Daiichi plus royalties. https://…
September 25th 2017, 9:09am
rosderek @rosderek
@mikegoodma & initiated P3 of CS-3150 in pts w/ diabetic nephropathy. Can't recall CS-3150 in any PT or valuation model for $EXEL
September 25th 2017, 9:09am
mikegoodma @mikegoodma
Esaxerenone achieves P3 primary endpt in hypertension. $EXEL in line for ~$150m in MS from Daiichi plus royalties. https://t.co/qMKHszsoPM
September 25th 2017, 9:09am
TopFiveTraders @TopFiveTraders
RT AlertTrade "#SwingTradeAlert $EXEL technical alerts: Expansion Pivot Sell Setup, MACD Bearish… … https://t.co/Dg30cCgKLl"
September 25th 2017, 8:09am
SwingTradeBot @SwingTradeBot
$EXEL technical alerts: Expansion Pivot Sell Setup, MACD Bearish Signal Line Cross, Expansion Bre... https://t.co/R8mMMMOolt
September 25th 2017, 8:09am
fvwhh14 @fvwhh14
@timeout2575 $EXEL anyone knows terms for milestones & royalties?
September 25th 2017, 8:09am
deepxdive @deepxdive
$EXEL Exelixis, Inc. breached its 50 day moving average in a Bearish Manner EXEL-US September 25, 2017… https://t.co/qbfbA4ckCl
September 25th 2017, 8:09am
ITRADEVOL @ITRADEVOL
$EXEL Price & Volume Summary https://t.co/zU3FTBlY8A
September 25th 2017, 8:09am
wilkinson991 @wilkinson991
$EXEL The finances and #chart are really pretty damn nice. Not much wrong here. No position and no idea what w happ… https://t.co/bb8CWdoQTP
September 25th 2017, 7:09am
wilkinson991 @wilkinson991
$EXEL Not in it anymore but sure wud like to see this one get itself straightened out. Always liked their finances here. #stocks #tradeideas
September 25th 2017, 7:09am
wosaikeneriki @wosaikeneriki
Meditor Group LTD Lifted Its Exelixis $EXEL Stake by $25.10 Million as Share Price Declined ...
September 25th 2017, 7:09am
mgutierrez_apex @mgutierrez_apex
$EXEL ESAX-HTN pivotal study in essential hypertension met primary objective; filing in Japan planned for Q1 2018
September 25th 2017, 6:09am
timeout2575 @timeout2575
$EXEL I thought they were only in oncology! What a pleasant surprise! https://t.co/CBvxJPWWWU
September 25th 2017, 6:09am
Briefingcom @Briefingcom
$EXEL: Exelixis reports ESAX-HTN pivotal study in essential hypertension met primary objective https://t.co/n62nBkxHdQ
September 25th 2017, 5:09am
stocknewsdotcom @stocknewsdotcom
$EXEL Reports ESAX-HTN pivotal study in essential hypertension met primary objective https://t.co/EkmZdPKRa7
September 25th 2017, 5:09am
1MinuteStock @1MinuteStock
Unicorn Bay rating for $EXEL is 2.84 out of 5. https://t.co/Lw8PCl4AEv
September 25th 2017, 5:09am
IRAMarketReport @IRAMarketReport
Exelixis, Inc. $EXEL Cut to Market Perform at Leerink Swann https://t.co/IkEUTscamN
September 25th 2017, 3:09am
chaffeybreeze @chaffeybreeze
Exelixis, Inc. $EXEL Cut to Market Perform at Leerink Swann https://t.co/Q4HU4395Rt
September 25th 2017, 3:09am
CFinancialNews @CFinancialNews
Exelixis, Inc. $EXEL to Post Q3 2017 Earnings of $0.08 Per Share, Leerink Swann Forecasts https://t.co/Mg0jPLeJEl
September 25th 2017, 2:09am
TheMarketsDaily @TheMarketsDaily
Exelixis, Inc. $EXEL to Post Q3 2017 Earnings of $0.08 Per Share, Leerink Swann Forecasts https://t.co/ngypAqtfzN
September 25th 2017, 2:09am
intercooleronli @intercooleronli
Exelixis, Inc. $EXEL to Post Q3 2017 Earnings of $0.08 Per Share, Leerink Swann Forecasts https://t.co/6x2pkaPJhW
September 25th 2017, 2:09am
StockGodd @StockGodd
$EXEL If pre market price can retest my overhead resistance level 24.67 & fail I'll look to short it to next pivot… https://t.co/B42JWqvaNb
September 25th 2017, 12:09am
realmaciej @realmaciej
RT @bradloncar: Filed under the category of things I didn't know. $EXEL has a hypertension program with Daiichi Sankyo.
September 24th 2017, 11:09pm
recervan @recervan
RT @odibro: $EXEL Update on Collaborator Daiichi ‘s P3 Clinical Progress with Esaxerenone (CS-3150), Including Top line results https://t.…
September 24th 2017, 10:09pm
IncredibleTrade @IncredibleTrade
$EXEL Provides Update on Collaborator Daiichi Sankyo's Ph3 Clinical Progress with Esaxerenone (CS-3150) --- https://t.co/a8DmvQhT2t
September 24th 2017, 9:09pm
ExelixisInc @ExelixisInc
Our partner @DaiichiSankyo reported positive top-line results from a ph. 3 trial in essential hypertension. https://t.co/xEYoBbcLgg $EXEL
September 24th 2017, 9:09pm
bradloncar @bradloncar
Filed under the category of things I didn't know. $EXEL has a hypertension program with Daiichi Sankyo.
September 24th 2017, 9:09pm
odibro @odibro
$EXEL Update on Collaborator Daiichi ‘s P3 Clinical Progress with Esaxerenone (CS-3150), Including Top line results https://t.co/Ot3RdsV4qP
September 24th 2017, 9:09pm
Allstocknews @Allstocknews
$EXEL Exelixis Provides Update on Collaborator Daiichi Sankyo's Phase 3 Clinical Progress with Esaxerenone (C From our Stock News Alerts App
September 24th 2017, 9:09pm
newswithvalue @newswithvalue
$EXEL: Exelixis Provides Update on Collaborator Daiichi Sankyo’s Phase 3 …: https://t.co/XzHdz4Jeyb
September 24th 2017, 9:09pm
VisualStockRSRC @VisualStockRSRC
$EXEL - Exelixis Provides Update on Collaborator Daiichi Sankyo’s Phase 3 Clinical Progress with Esaxerenone https://t.co/sCofyXea9A
September 24th 2017, 9:09pm
newswithvalue @newswithvalue
$EXEL $INCY: 3 Monster Biotech Stocks in the Making: https://t.co/69jVxkC8kg
September 24th 2017, 9:09am
TickerReport @TickerReport
Stelios Papadopoulos Sells 10,000 Shares of Exelixis, Inc. $EXEL Stock https://t.co/qQ6xuoHFmT
September 24th 2017, 7:09am
emq_news @emq_news
Stelios Papadopoulos Sells 10,000 Shares of Exelixis, Inc. $EXEL Stock https://t.co/z7ZdzCFOuZ
September 24th 2017, 7:09am
TickerReport @TickerReport
Stelios Papadopoulos Sells 10,000 Shares of Exelixis, Inc. $EXEL Stock https://t.co/jj103nqmmx
September 24th 2017, 7:09am
emq_news @emq_news
Somewhat Positive Media Coverage Somewhat Unlikely to Affect Exelixis $EXEL Stock Price https://t.co/ttq1FXxnJ1
September 24th 2017, 4:09am
TickerReport @TickerReport
Somewhat Positive Media Coverage Somewhat Unlikely to Affect Exelixis $EXEL Stock Price https://t.co/S5Czff5Kik
September 24th 2017, 4:09am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.